New York, NYNCT06843967Now EnrollingIRB Ready

Liposarcoma Clinical Trial in New York, NY

Access cutting-edge liposarcoma treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Memorial Sloan Kettering Cancer Center

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions...

Expert Care in New York

Access liposarcoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related liposarcoma treatment provided free

Apply for This New York Location

Check if you qualify for this liposarcoma clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Liposarcoma Study in New York

The purpose of this study is to find out whether mirdametinib in combination with palbociclib is an effective and safe treatment for people with metastatic, recurrent, and unresectable liposarcoma. This study will test different doses of mirdametinib in combination with a fixed dose of palbociclib to find the best safe dose for further testing.

Sponsor: Memorial Sloan Kettering Cancer Center

Who Can Participate

Inclusion Criteria

Phase I only:
A diagnosis of unresectable, recurrent, or metastatic DDLPS
Measurable disease as defined by RECIST 1.1 Phase II only:
A diagnosis of unresectable, recurrent (e.g. recurrent retroperitoneal) or metastatic DDLPS
Any number of prior lines of therapy
Measurable disease and evidence of progression of disease as defined by RECIST 1.1 (including newly diagnosed disease, new disease sites in a patient who was previously NED, or a 20% growth of existing lesions within 6 months of registration)
Age ≥ 18 years
ECOG performance status ≤ 2
Adequate organ and marrow function as defined below (ULN indicates institutional upper limit of normal):
Absolute neutrophil count ≥ 1.5 x 109/L
Hemoglobin ≥ 9.0 g/dL
Platelets ≥ 100 x 109/L
Total bilirubin ≤ 1.5 X ULN OR Direct bilirubin ≤ ULN for subjects with total bilirubin levels \> 1.5 ULN, except patients with Gilbert's disease (≤3x ULN)
AST (SGOT) /ALT (SGPT) ≤ 1.5 x institutional U

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT06843967) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Liposarcoma Treatment Options in New York, NY

If you're searching for liposarcoma treatment options in New York, NY, this clinical trial (NCT06843967) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liposarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all liposarcoma clinical trials near you to find additional studies recruiting in your area.

More Sarcoma Trials in New York, NY

See all sarcoma clinical trials recruiting in New York — not just this study.

Browse Sarcoma Trials in New York →

Browse More Trials by Condition

Sarcoma TrialsSleep Apnea TrialsSarcoma Soft Tissue TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY